- Information Technology (58)
- Litigation / Dispute Resolution (52)
- Company/Commercial (23)
- Media/Entertainment/Sport (19)
- Pharma/Biotech (14)
- Regulatory and compliance (12)
- Tax (11)
- Corporate (9)
- Employment (9)
- Commodities (7)
- Licensing/Gaming/Betting (7)
- Privacy and reputation (6)
- Telecoms (6)
- Banking / Finance (5)
- Energy (5)
- Healthcare (5)
- Real Estate (5)
- Environment (4)
- Financial services (4)
- Competition/EU (3)
- Crime (3)
- Funds (3)
- Business Tax (2)
- Insolvency & restructuring (2)
- Insurance/reinsurance (2)
- Personal tax / Trusts (2)
- Transport (Including aviation and shipping) (2)
- Agriculture (1)
- Human Rights (1)
- In-House (1)
- Pensions (1)
- Planning (1)
- Public Sector/Local Authority (1)
Sort By: Newest first | Oldest first
One current hot topic ‘good faith’. Can it be implied into contracts? If so, what would that mean in practice?
Australian Full Federal Court confirms position on the patentability of computer-implemented business methods
The Full Court of the Australian Federal Court has handed down its much awaited decision in Research Affiliates LLC v Commissioner of Patents.
On 5 November 2014, a group of journalists placed about 540 rulings granted by the Luxembourg tax administration to some 340 companies active in a large number of industries.
Law à la Mode — understanding the EU Consumer Rights Directive; free zones in the UAE; unregistered design rights; and more
The German editorial team presents the 14th edition of Law à la Mode, the quarterly legal magazine brought to you by DLA Piper’s fashion, retail and design group.
All-In@EiG 2014 — gaming in the cloud; patents on gaming and gambling technology; legal issues surrounding Bitcoin; and more
To coincide with the 13th European iGaming Congress and Expo, DLA Piper’s gaming team has launched All-In@EiG 2014.
Welcome to the sixth issue of Spotlight on Belgium. DLA Piper’s Belgian team brings you up to speed with the latest legal updates.
This guide provides sound, practical advice on the relevant laws and regulations for foreign companies looking to invest in Australia.
Manufacturing Matters — exploring a crisis in hindsight; safeguarding your stakeholders’ personal data across borders; and more
DLA Piper has released the 11th edition of Manufacturing Matters, which provides a round-up of legal news, updates and commentary for the manufacturing sector.
In D’Arcy v Myriad Genetics, five judges of the Full Federal Court of Australia have confirmed that isolated nucleic acid sequences are patentable subject matter in Australia.
Intellectual Property and Technology News — service integration in the technology and sourcing space; and more
Intellectual Property and Technology News (Asia Pacific) is a biannual publication from DLA Piper that offers perspectives, analysis and visionary ideas.
An opposer establishes a prima facie case for lack of bona fide intent to use a mark when it can show that the applicant does not have any documentation evidencing steps to use the mark in US commerce.
Supreme Court Corner: Nautilus Inc v Biosig Instruments Inc; Limelight Networks Inc v Akamai Techs; and more
DLA Piper has released the Q3 2014 issue its Supreme Court Corner publication.
Debates on the laws and regulations that will govern biosimilar products have been raging for some time.
The growth of R&D budgets and the increase in the number of patents issued to energy companies will likely result in a rise in patent disputes between competitors in the energy sector.
Intellectual Property and Technology News — state biosimilars laws are evolving; surviving a trademark opposition challenge; and more
DLA Piper has released issue 23 of its Intellectual Property and Technology News, which reports on worldwide developments in IP and technology law.
IP Rights in Data Handbook: protecting and exploiting IP in data, big data and databases internationally
DLA Piper’s second-edition IP Rights in Data Handbook now covers 20 jurisdictions and includes top tips from local professionals on how best to exploit big data.
Life Sciences Spotlight: Chinese regulatory enforcement action not slowing down; patent strategies and loyalty discounts; and more
DLA Piper has released the fourth edition of Life Sciences Spotlight, which discusses developments in the sector across the Asia-Pacific region.
Life Sciences Spotlight: Chinese regulatory enforcement action showing no signs of slowing down; and more
Welcome to the fourth edition of Life Sciences Spotlight.
Sports, Media and Entertainment Intelligence — Aereo ‘astonishes’ broadcasters with new legal strategy; and more download
Sports, Media and Entertainment Intelligence is the global monthly publication from DLA Piper’s sports, media and entertainment group.
European Commission fines Servier and five generic companies for curbing entry of cheaper versions of cardiovascular medicine
The European Commission has imposed fines totalling €427.7m on the French pharmaceutical company Servier and five producers of generic medicines.